Lecture 34 - Other Muscular Dystrophies Flashcards

1
Q

How are muscular dystophies classified?

A
  1. Age of onset
  2. Pattern of weakness
    • Muscular dystrophies have typical patterns of muscle involvement (despite same genes in the muscles)
    • Thorough physical examination is performed
  3. Pattern of inheritance
    • e.g. X-linked inheritance immediately narrows it down
  4. Involvement of other systems
    • e.g. GIT
  5. Specific abnormalities on muscle biopsies
    • Muscle biopsy not always needed
  6. Cause gene (where identified)
    • Sometimes gene mutations have more than one clinical phenotype and thus also presentation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Why is it important to make a diagnosis?

A
  1. Information about disease
    • Life expectancy
    • Prognosis
  2. Allows monitoring for disease specific complications
    • Cardiac
    • Respiratory etc.
  3. Appropriate treatment
    • and to avoid inappropriate treatment
  4. Genetic counselling
    • Always of benefit
    • Assessment of risk in siblings
    • Identification of carriers (because carriers can have health problems)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
Compare the following in different forms of muscular dystrophy:
 • Age of onset
 • Pattern of weakness
 • Pattern of inheritance
 • Involvement of other systems
 • Muscle biopsy
A

Analysis of all these features differentiate between the various muscular dystrophies

Age of onset:
• Infantile onset: Congenital muscular dystrophy
• Adult onset: Limb-girdle muscular dystrophy

Pattern of weakness:
• Generalised: all over the body including face
• Focal: e.g. Rigid-spine syndrome

Inheritance pattern:
Look for:
• Male to male transmission
• Successive generations affected

Involvement of other systems:
• Brain: structural abnormalities, cognitive abnormalities
• Musculoskeletal: spinal rigidity; scoliosis; joint contractures
• Endocrine systems
• Eye: cataracts; structural abnormalities

Muscle biopsy
• Normal: uniform muscle fibres etc.
• Dystrophic muscle: connective tissue, necrosis, variation in fibres size, fat etc.
• This tells us that it is a muscle dystrophy, but can’t really differentiate between them

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the features of muscular dystrophy due to FKRP gene mutation?

A
  • Large head
  • Early onset joint contractures
  • Significant cognitive abnormalities (mental retardation)
  • Facial muscle weakness
  • CK in the 5000’s: muscular degeneration
  • Abnormal myelination (dye-myelination)
  • Cerebellar cysts

This is a very characteristic pattern of features that indicate FKRP gene mutation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe the process of muscle biopsy, and how this can lead to diagnosis

A
  1. Local anaesthetic
  2. Needle extraction of muscle about the size of a die
  3. Sent off for:
    • Histology
    • Electron microscopy
    • Specific testing (based on what one thinks is going on)

e.g.
• Western blot
• Mutation analysis
• Immunohistochmistry

Diagnosis:
There is a whole battery of tests that is performed
It is through weighing up of the results of all these different tests that a specific diagnosis can be made.
A single test won’t be definitive

  1. Invisible stitches, and goes home the same day

Not a major procedure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the use of immunohistochemistry in muscle biopsy

A

Fluorescent mAbs against specific proteins that might be associated with the disease process:

  1. Membrane protein
    • Missing in dystrophic muscle
    • Present in normal muscle
    • Decreased staining in some dystrophies (could be primary or secondary…)
  2. α-dystroglycan
    (Anchors many proteins in the sarcolemmal membrane)
    • Normal staining → normal muscle
    • Abnormal staining → doesn’t give a specific diagnosis, just indicates that there is a problem in this protein
    • α-dystroglycan is absent both in DMD and Limb girdle muscular dystrophy type IC
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Give some features of Myotonic Dystrophy (DM1):
• Mode of inheritance
• Prevalence
• Systems involved

A
  • Most common dystrophy seen in adults
  • Chromosome 19
  • 1/8000
  • Autosomal dominant inheritance
  • Variable severity
  • Anticipation
  • Muscle biopsy not very helpful

A multi-system disorder
• Proximal as well as distal muscle affected
• Smooth muscle affected (GIT and uterine problems)
• Cognitive deficits
• Excessive somnolence
• Personality changes
• Cataracts
• Endocrine dysfunction (diabetes, infertility)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is ‘Anticipation’?

A

Disease becomes worse in successive generations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the clinical presentations of myotonic dystrophy?

A

Three phenotypes:

  1. Congenital
    • Very severe
    • Presentation in first 4 weeks of life
  2. Classic DM1
    • Presents in adolescence of adulthood
    • Most common
3. Mild DM1
 • Adult onset
 • Mild phenotype
 • May only be cataracts and mild myotonia
 • Can be missed
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

When does congenital myotonic dystrophy present?

A

First 4 weeks of life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Give the symptoms of congenital myotonic dystrophy

What is the prognosis for these babies?

A
  • Hypotonia (floppy)
  • Facial and proximal muscle weakness
  • Delayed motor development
  • Feeding difficulties
  • Severe intellectual deficits

Prognosis:
Very commonly death within first four weeks due to respiratory failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the features of classical myotonic dystrophy

A
  • Immobility of facial muscle (no facial expression)
  • Frontal balding
  • Cataracts
  • Wasting of sternocleidomastoid muscle
  • Gynecomastia (benign enlargement of breast tissue in males)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is myotonia?

When is it seen?

A

“Delayed relaxation of muscles after contraction”

  • Uncomfortable, but not extremely debilitating
  • Useful for diagnosis

Symptom observed not solely in myotonic dystrophy, but in a number of conditions
• Not seen in babies with DM1
• Present in affected parents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the importance of muscle biopsy in DM1

A

(Myotonic dystrophy)

Not very helpful because the muscle:

Does not look particular dystrophic

Observations:
• Not very dystrophic, however:
• Many central nuclei
• Ringbinden (aberrant myofibrils wrapping themselves around others)

Often not necessary, because there is a good genetic test for DM1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the genetic basis of myotonic dystrophy (DM1)

Is there a good genetic test?

What is the pattern of inheritance?

A

DMPK gene

Expanded CTP trinucleotide repeats

Normal: 5-35
Premutation: 35-49
 • Slight increase in n° of repeats
 • Asymptomatic
 • Increased chance of passing disease on to offspring
Full penetrance: >50 repeats
 • DM1

Genetic test:
• 100% sensitive

Inheritance:
• Autosomal dominant
• Exhibits anticipation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe the mechanism of anticipation in DM1

Transmission from which parent shows anticipation?

A

Anticipation: increase disease severity and decreasing age of onset in successive generations

  • DMPK CTP alleles of >35 are unstable
  • Repeats can expand in meiosis
  • Offspring can inherit repeat sequences that are much longer that the parents’

• Anticipation usually occurs with maternal transmission

17
Q

Describe a case of anticipation

A

In DM1

Grandmother
• Cataracts

Mother:
• Decreased facial expressions

Son:
• Congenital muscular dystrophy
• Very severe
• Severe cognitive impairment

18
Q

Describe the molecular pathogenesis of DM1

A
  1. RNA transcribed from expanded DMPK gene
  2. RNA form hairpin secondary structures
  3. Hairpins bind specific proteins and sequester them in the nucleus
    • MBNL1: Muscleblind-like 1
  4. Loss of function of MBNL1
    • Because it has been sequestered
  5. Up-regulation of CUGBP1
    • Because it is no longer being inhibited by MBNL1

    • Disrupted regulation of alternative splicing
    • mRNA translation disruption
    • Decrease mRNA stability
  6. Normally in the embryo:
    • Normally increased CUGBP1 and decreased MBNL1
    • During development, CUGBP1 levels drop and MBNL1 levels increase
    • In DM1, the decreased levels of MBNL1 lead to:
  7. Enhanced embryonic isoform expression in adults
    • CUGBP1 splices RNA to bring about the expression of different isoforms
    • Over-expression of embryonic isoforms leads multiple disease symptoms:
  8. Symtoms due to disrupted splicing
    • Insulin-receptor like 1 gene → insulin resistance
    • Chloride channel → myotonia
    • Troponin T in heart → cardiac defects, arrhythmia
19
Q

Which two proteins does the toxic RNA from the BMPK gene bind?

Describe the relationship between these proteins

A

MBNL1

CUGBP1

Reciprocal inhibition

20
Q

What are the possible therapies for DM1?

A

RNA-based inhibition of toxic CUG-expanded RNA species

  1. Small molecule inhibitors
  2. RNA-interference-mediated suppression of mutated DMPK transcripts
  3. Antisense oligonucleotides mediated knockout of DMPK
21
Q

List the main features of Limb girdle muscular dystrophies
• Age of onset
• Who is affected
• Clinical presentation
• Pathology
• Differentiation between the various subtypes

A
  • Progressive muscle disorders
  • Collection of disorders
  • Onset: 10-60 years
  • Males and female equally affected
Presentation:
 • Muscle weakness and hypertrophy
 • First in pelvic girdle
 • Then shoulder
 • Respiratory and cardiac involvement
 • No central nervous system involvement

Pathology:
• Cytoskeletal
• (rather than contractile)

Various subtypes
• Differentiated based on:
- Inheritance
- Pattern of weakness

Inheritance:
LGMD type 2: Autosomal recessive
LGMD type 1: autosomal dominant

22
Q

Which MDs have X-linked inheritance?

A

DMD

BMD

23
Q

How is LGMD diagnosed?

A

Only get a specific diagnosis in about 75% of cases

  1. Clinical presentation
    • Pattern of weakness
    • Pattern of inheritance
    • Family history
  2. Creatine kinase levels
  3. Muscle histology
    • Immunohistochemistry
  4. Genetic testing
24
Q

Describe an example of how pattern of weakness can guide diagnosis?

A

Early onset contractures
→ Emery-Dreifuss Muscular Dystrophy
(an X-linked LGMD)

25
Q

Describe the muscle pathology in LGMD

A

Features observed:
• Vaculoes

• Myotilin accumulation in LGMD type 1 (observed with myotilin stain)

These features are highly suggestive of LGMD and, more specifically, LGMD type 1

This would prompt specific genetic testing

26
Q

What is the typical pattern of weakness in LGMDs?

What is the underlying cause of this?

A

Prominent contractures:
• Achilles tendons
• Elbows
• Spine

Humeroperoneal muscle weakness

Underlying cause:
• Lamin A/C mutations

27
Q

Compare mode of inheritance in:
• LGMD type 1
• LGMD type 2

Which is more common?

A

LGMD type 1: autosomal dominant

LGMD type 2: autosomal recessive
• more common

28
Q

What other problems are often seen in LGMD type 2?

A

Cardiomyopathy

Respiratory involvement

29
Q
Describe the features of Facioscapulohumeral muscular dystrophy (FSHD)
 • Mode of inheritance
 • Prevalence
 • Age of onset
 • Symptoms
A
  • Dominantly inherited
  • 1/20 000
  • Age of onset: 20
Symptoms:
 • Very characteristic pattern of muscle weakness
 • Facial weakness
 • Scapula winging
 • Proximal arm weakness
 • Leg weakness (less prominent)
 • Proneal weakness → foot drop
 • Sleep with eyes open
 • Can't whistle
 • Poorly developed pectoral muscles
 • Chest deformities: pigeon chest (prominent chest wall)
30
Q

Describe the selective muscle involvement in FSHD

A

• Patchy and asymmetric
• Weakness mostly on dominant side
• Beevor sign:
- belly button goes up when head raised from a supine position

Not understood why it is so patchy

31
Q

Describe the genetic basis for FSHD

A
  • Gene still unidentified
  • Dominantly inherited
  • 90% cases map to Chromosome 4q
  • 10% cases sporadic

Incomplete penetrance:
• 30% of people affected have no symptoms throughout life
• Symptoms more common in males than females

• Germline mosaicism occasionally seen

D4Z4 repeat sequence:
• On chromosome 4
• Affected in most cases FSHD, but we don’t know how this brings about the disorder

32
Q

Compare number of D4Z4 repeats in normal cases, and in people with FSHD

Finish the sentence:
The fewer n° of repeats, …

A

Normal: 12-96 copies
FSHD: <8 copies

The fewer n° of repeats:
• The more severe the FSHD
• The earlier the onset

33
Q

Why is genetic diagnosis of FSHD from the D4Z4 repeat sequence problematic?

How has this been overcome?

A

– Problem –
There is a very similar sequence on chromosome 10
(Homologous)

Difficult to differentiate between the two

5% of people with FSHD have a negative gene test

There can also be translocation of the repeats to chromosome 10 which are not picked up on the test

– New approach –

More complex gene probes
Able to distinguish between changes on 4q and 10q

These new probes also pick up translocations to chromosome 10

34
Q

When can mutation occur, bringing about FSHD?

Why is this sometimes tricky?

A
  1. Somatic mutations
    • Mutation in the mothers somatic cells (but she’s not affected)

– New mutations –
2. Germline mosaicism
• Mutation during development (of the mother)
• Some of mothers cells affected: the gametes
• Somatic cells do not have the mutation

  1. De novo
    • e.g. mutation in a single sperm

Makes it hard for genetic counselling, as it is unclear whether the mother has zero chance of having another child with FSHD

35
Q

Which other muscular dystrophies were talked about in this lecture?

A

DM1: Myotonic dystrophy

LGMD: Limb girdle muscular dystrophies

FSHD: Facioscapulihumoral dystrophy

36
Q
Compare inheritance of the following muscular dystrophies:
 • DMD
 • FSHD
 • LGMD type 1
 • BMD
 • LGMD type 2
 • EDMD
 • DM1
A

DMD: X-linked

FSHD: autosomal dominant

LGMD type 1: autosomal dominant

BMD: X-linked

LGMD type 2: autosomal recessive

Emery Dreifuss MD: X-linked

DM1: autosomal dominant